Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 1 5Phase 3 4Phase 1/2 3Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 3Lymphoid 2Breast 2Plasma cell 1

Conditions

Lymphoma, T-Cell 1Lymphoma 1

Interventions

Cyclophosphamide 47Rituximab 34Exercise 25fludarabine phosphate 24Methotrexate 24Blood Specimen Collection 23Vincristine 21Cytarabine 21Radiotherapy 20Filgrastim 19Peripheral Blood Stem Cell Transplantation 18Whole-Body Irradiation 17Prednisone 16Melphalan 16Etoposide 16Cyclosporine 16Methods 15Dexamethasone 15Busulfan 15Antilymphocyte Serum 15fludarabine 14Doxorubicin 14Educational Status 13Mycophenolic Acid 12Magnetic Resonance Spectroscopy 11Early Intervention, Educational 11Therapeutics 10Surveys and Questionnaires 9Standard of Care 9Prednisolone 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × liposomal doxorubicin × Lymphoid × Clear all
NCT00161239 2009-12-11

LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma

Rutgers, The State University of New Jersey

Phase NA Terminated
64 enrolled
Lymphoid

Lymphoma, T-Cell

NCT00141648 2009-10-01

Chemotherapy and Radiotherapy for Osteolymphoma

Trans Tasman Radiation Oncology Group

Phase NA Completed
70 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡